NPR logo

MIT, ImClone Battle in Court over Cancer Drug Patent

  • Download
  • <iframe src="https://www.npr.org/player/embed/1924179/1924180" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
MIT, ImClone Battle in Court over Cancer Drug Patent

Health

MIT, ImClone Battle in Court over Cancer Drug Patent

MIT, ImClone Battle in Court over Cancer Drug Patent

  • Download
  • <iframe src="https://www.npr.org/player/embed/1924179/1924180" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Officials at the Massachusetts Institute of Technology are suing ImClone, the makers of a promising new cancer drug called Erbitux. The university says the drug is manufactured using technology patented by the school 20 years ago. Fights between universities and companies that use their research are becoming much more common. NPR's Snigdha Prakash reports.